IMMUCELL CORP /DE/ Logo

IMMUCELL CORP /DE/

Develops and markets products to improve the health of dairy and beef cattle.

ICCC | US

Overview

Corporate Details

ISIN(s):
US4525253062
LEI:
Country:
United States of America
Address:
56 EVERGREEN DR, 4103 PORTLAND

Description

ImmuCell Corporation is an animal health company that develops, manufactures, and markets scientifically-proven products to improve the health and productivity of dairy and beef cattle. The company focuses on disease prevention as a means to reduce the use of antibiotics. Its flagship product line, First Defense®, is a USDA-accredited, colostrum-derived product providing newborn calves with immediate immunity against the primary viral and bacterial causes of scours. ImmuCell is also developing Re-Tain®, a purified nisin-based intramammary treatment for subclinical mastitis in dairy cows, which is pending regulatory approval. The company's core competency lies in its ability to concentrate, purify, and quantify specific colostrum antibodies on a commercial scale to create cost-effective health solutions for producers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 22:11
FORM 4/A OLIVIER TE BOEKHORST
English 6.8 KB
2025-12-03 22:14
FORM 4 O TE BOEKHORST
English 6.5 KB
2025-11-28 14:12
FORM 4 D TOMSCHE
English 6.4 KB
2025-11-20 22:36 English 9.8 KB
2025-11-13 22:08
FORM 10-Q
English 1.7 MB
2025-11-13 22:07
FORM 8-K
English 85.1 KB
2025-11-12 14:43
FORM 4
English 7.0 KB
2025-11-07 13:41
FORM 3 O. TE BOEKHORST
English 6.7 KB
2025-11-04 22:08
FORM 8-K
English 71.2 KB
2025-10-07 22:06
FORM 8-K EARNINGS
English 74.4 KB
2025-09-30 22:05
FORM 8-K
English 169.6 KB
2025-08-25 14:00
CURRENT REPORT
English 82.2 KB
2025-08-14 22:06
QUARTERLY REPORT
English 1.5 MB
2025-08-14 22:05
CURRENT REPORT
English 103.8 KB
2025-08-12 22:21
CURRENT REPORT
English 348.0 KB

Automate Your Workflow. Get a real-time feed of all IMMUCELL CORP /DE/ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUCELL CORP /DE/

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUCELL CORP /DE/ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.